Welcome to LookChem.com Sign In|Join Free
  • or
(S)-(-)-2-(a-methylmethanamine)-1H-benzimidazole, min. 98% (S)-Me-BIMAH is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

925689-54-9

Post Buying Request

925689-54-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

925689-54-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 925689-54-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,2,5,6,8 and 9 respectively; the second part has 2 digits, 5 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 925689-54:
(8*9)+(7*2)+(6*5)+(5*6)+(4*8)+(3*9)+(2*5)+(1*4)=219
219 % 10 = 9
So 925689-54-9 is a valid CAS Registry Number.

925689-54-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name 1H-Benzimidazole-2-methanamine, α-methyl-, dihydrochloride , (αS)-

1.2 Other means of identification

Product number -
Other names (1S)-1-(1H-BENZIMIDAZOL-2-YL)ETHANAMINE

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:925689-54-9 SDS

925689-54-9Downstream Products

925689-54-9Relevant academic research and scientific papers

BENZIMIDAZOLE COMPOUNDS THAT ARE VITRONECTIN RECEPTOR ANTAGONISTS

-

Page/Page column 30-31, (2008/06/13)

The present invention provides compounds having formula (I) wherein n, p, q and r are each independently selected from 0 or 1; a, b, c, and d each independently represents a carbon or nitrogen atom, with the proviso that no more than two of a, b, c, and d are nitrogen atoms; Y and Y' each independently represents 1-4 optional substituents selected from alkyl, alkoxy, halo, -CF3, and -C(O)OH; R, R, R and R are H or specified substituents; R, R, R, R, R, R, R and R are independently selected from H or C1-C3 alkyl; or a biolabile ester thereof, or a pharmaceutically acceptable salt thereof. Also provided are methods of using these compounds for treating vitronectin-mediated disorders, e.g., cancer, retinopathy, artherosclerosis, vascular restenosis, and osteoporosis.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 925689-54-9